Envestnet Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Envestnet Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$418K	Buy	+3,769	New	+$341K	﹤0.01%	4213

Other funds holding RYTM

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Envestnet Asset Management's RYTM Position: Q2 2026 in Review

Envestnet Asset Management opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 3,769 shares worth $418K. The stake represents ﹤0.01% of the portfolio and ranks #4213 among its holdings.

78 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

Envestnet Asset Management held 3,769 shares of Rhythm Pharmaceuticals worth $418K as of Q2 2026.
Rhythm Pharmaceuticals was a new Envestnet Asset Management position in Q2 2026.
Rhythm Pharmaceuticals made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4213 holding.
78 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.